On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies

European Journal of Nuclear Medicine

Volumn 26, Issue 11, 1999, Pages 1489-1492

  Hoekstra, C J ^a   Hoekstra, O S ^a   Lammertsma, A A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AORTA; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; VENOUS BLOOD;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032724254     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050484     Document Type: Article

References (19)

1. Bury T, Dowlati A, Paulus P, Corhay JL, Hustinx R, Ghaye B, Radermecker M, Rigo P. Whole-body 18FDG positron emission tomography in the staging of non- small cell lung cancer. Eur Respir J 1997; 10: 2529-2534.
2. 18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996; 23: 717-735.
3. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
4. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
5. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography. 1. Effect of object size. J Comput Assist Tomogr 1979; 3: 299-308.
6. 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab 1998; 18: 716-723.
7. Ohtake T, Kosaka N, Watanabe T, Yokoyama I, Moritan T, Masuo M, Iizuka M, Kozeni K, Momose T, Oku S. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med 1991; 32: 1432-1438.
8. Sandell A, Ohlsson T, Erlandsson K, Strand SE. An alternative method to normalize clinical FDG studies. J Nucl Med 1998; 39: 552-555.
9. Avril N, Bense S, Ziegler SI, Dose J, Weber W, Laubenbacher C, Romer W, Janicke F, Schwaiger M. Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med 1997; 38: 1186-1191.
10. Hunter GJ, Hamberg LM, Choi N, Jain RK, McCloud T, Fischman AJ. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. Clin Cancer Res 1998; 4: 949-955.
11. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993; 11: 2101-2111.
12. Zasadny KR, Wahl RL. Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images. J Nucl Med 1996; 37: 371-374.
13. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ. Performance evaluation of a whole-body PET scanner using the NE-MA protocol. National Electrical Manufacturers Association. J Nucl Med 1997; 38: 1614-1623.
14. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
15. Lin KP, Huang SC, Choi Y, Brunken RC, Schelbert HR, Phelps ME. Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. Phys Med Biol 1995; 40: 629-642.
16. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989; 30: 359-366.
17. Li X, Feng D, Lin KP, Huang SC. Estimation of myocardial glucose utilisation with PET using the left ventricular time-activity curve as a non-invasive input function. Med Biol Eng Comput 1998; 36: 112-117.
18. Wu HM, Huang SC, Allada V, Wolfenden PJ, Schelbert HR, Phelps ME, Hoh CK. Derivation of input function from FDG-PET studies in small hearts. J Nucl Med 1996; 37: 1717-1722.
19. Nuyts H, Maes A, Vrolix M, Schiepers C, Schelbert H, Kuhle W, Bormans G, Poppe G, Buxton D, Suetens P, De Geest H, Mortelmans L. Three-dimensional correction for spillover and recovery of myocardial PET images. J Nucl Med 1996; 37: 767-774.